Menu

Welcome to Colonis

Colonis Pharma Limited is a product development business which takes niche pharmaceutical products through the regulatory pathway to achieve licensed and/or regulated product (medical device) status.

With an ethos of delivering value in healthcare in therapeutic areas with often unmet clinical needs, Colonis Pharma Limited has a strong pipeline of licensed pharmaceuticals and medical devices.

Read More

What we do

Colonis Pharma Limited is a product development business which takes niche pharmaceutical products through the regulatory pathway to achieve licensed and/or regulated product (medical device) status.

Colonis Pharma Limited was established 2012 and is now part of the Quantum Pharma Group, after being wholly acquired following the flotation of Quantum Pharma PLC on the AIM market in December 2014.

Quantum Pharma is a service-led, niche pharmaceutical manufacturer, developer and supplier to the retail pharmacy, pharmaceutical wholesale, hospital, homecare and care home markets. Each of the Group’s companies operate through one of three divisions - Specials, Niche Pharmaceuticals and Medication Adherence. Collectively, they offer a portfolio of innovative and complementary products and services.

With the successful launch of its first product in January 2015, Colonis Pharma Limited entered the licensed pharmaceutical market.

Get in touch

Disclosure of Certain Transfers of Value from Colonis Pharma Limited to Health Professionals and Healthcare Organisations in 2015

Methodology

Colonis Pharma Limited (part of the Quantum Group) has agreed to comply with the ABPI Code of Practice and accept the jurisdiction of the PMCPA.

The Colonis Pharma products available to the UK market during 2015 were predominantly medical devices and one licensed pharmaceutical product. During 2015 there were no transfers of value in relation to the pharmaceutical product that was on the market. Colonis have determined that it is best practice to apply the principles of 'disclosure of transfers of value' to their activities in respect of medical devices. Disclosure for medical devices has been made at an aggregate level.

During 2015 Colonis Pharma made transfers of value in respect of their medical devices in the following areas:

  • Sponsorship for meeting attendance (to cover registration fees, travel and accommodation)
  • Grants
  • Benefits in kind

These have been disclosed at an aggregate level in the template produced by the ABPI which is located on the Colonis website. This information will remain in the public domain for 3 years, and be retained by Colonis for 5 years after the calendar year to which it relates.

Read more Disclosure 2015

General Enquiries

For general enquiries please email info@colonis.co.uk or call us on +44 (0)1892 739400

Medical Information

For medical and product information please email medinfo@colonis.co.uk or call +44 (0)1892 739403

Reporting Side Effects

For reporting side effects please email safety@colonis.co.uk or call +44 (0)1892 739404

Office Address

Colonis Pharma Limited
Niche Pharmaceutical Division of Quantum Pharma
Pinewood
Chineham Business Park
Crockford Lane
Basingstoke
Hampshire, RG24 8AL
United Kingdom